Discover the latest advancements in breast cancer treatment at the 24th Annual International Congress, featuring expert ...

Theresa Medina, MD, associate professor of medicine-medical oncology at the University of Colorado Cancer Center, Anschutz ...

FDA approves tafasitamab with lenalidomide and rituximab, offering a groundbreaking chemotherapy-free treatment for relapsed ...

FDA updates CAR T-cell therapy labels for liso-cel and ide-cel, easing monitoring requirements and expanding access for ...

Recent studies reveal promising outcomes for discontinuing TKI therapy in select patients with Philadelphia ...

Panelists discuss how to approach a 67-year-old man with advanced polycythemia vera who is resistant to hydroxyurea, ...

Targeted Oncology connects oncology professionals with updates on immunotherapy, biomarkers, cancer pathways, and targeted ...

A recent trial reveals that nivolumab combined with chemotherapy significantly improves survival rates in older patients with ...

During a live event, Fengting Yan, MD, PhD, discussed safety outcomes from the TROPION-Breast01 and supportive care for ...

Despite major advances, real-world data show diminishing survival outcomes and treatment-limiting toxicities in second line ...

Surbhi Sidana, MD, discusses updates from the CARTITUDE-4 study assessing the CAR T therapy cilta-cel in patients with ...

Discover how data analytics transforms health care by reducing costs, improving patient outcomes, and enhancing operational ...